Cargando…

Brexucabtagene autoleucel for mantle cell lymphoma, B-cell precursor acute lymphoblastic leukaemia

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Therapeutic Guidelines 2023
Materias:	New Drug
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664098/ http://dx.doi.org/10.18773/austprescr.2023.011

Ejemplares similares

Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
por: Aydilek, Enver, et al.
Publicado: (2023)

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
por: Iacoboni, Gloria, et al.
Publicado: (2022)

Acalabrutinib for mantle cell lymphoma, chronic lymphocytic leukaemia
Publicado: (2020)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

P1155: BREXUCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ROUTINE PRACTICE: UPDATED REPORT FROM THE US LYMPHOMA CAR T CONSORTIUM
por: Wang, Y., et al.
Publicado: (2022)

Zanubrutinib for mantle cell lymphoma, Waldenström’s macroglobulinaemia
Publicado: (2021)

S220: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA: A CIBMTR SUBGROUP ANALYSIS BY PRIOR TREATMENT
por: Ahmed, Nausheen, et al.
Publicado: (2023)

P1454: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR THE TREATMENT OF RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) IN THE UNITED STATES (US)
por: Locke, F., et al.
Publicado: (2022)

Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
por: Shah, Bijal D, et al.
Publicado: (2023)

Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada
por: Ball, Graeme, et al.
Publicado: (2022)

Pattern of brexucabtagene autoleucel-related neurotoxicity on magnetic resonance imaging of the brain in a patient with relapsed/refractory B-cell acute lymphoblastic leukemia and prior leptomeningeal disease
por: Dean, Erin A., et al.
Publicado: (2023)

S312: IS BREXUCABTAGENE AUTOLEUCEL A COST-EFFECTIVE TREATMENT FOR REFRACTORY/RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA? A PHARMACOECONOMIC ANALYSIS IN THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM.
por: Marchetti, Monia
Publicado: (2023)

Polatuzumab vedotin for B-cell lymphoma
Publicado: (2020)

Axicabtagene ciloleucel for B-cell lymphoma
Publicado: (2021)

P367: LONG-TERM OUTCOMES OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH BREXUCABTAGENE AUTOLEUCEL IN ZUMA-3 BY AGE, PRIOR THERAPIES, AND SUBSEQUENT TRANSPLANT
por: Shah, Bijal, et al.
Publicado: (2023)

Asciminib for chronic myeloid leukaemia
Publicado: (2022)

Treosulfan for acute myeloid leukaemia and myelodysplastic syndrome in adults, and malignant and non-malignant haematological diseases in children
Publicado: (2023)

Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
Publicado: (2022)

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

Tisagenlecleucel for B-cell cancers
Publicado: (2019)

Precursor B‐cell acute lymphoblastic leukaemia—a global view
por: Biondi, Andrea, et al.
Publicado: (2021)

Cemiplimab for cutaneous squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer
Publicado: (2022)

Lurbinectedin for small cell lung cancer
Publicado: (2021)

Brigatinib for non-small cell lung cancer
Publicado: (2020)

Lorlatinib for non-small cell lung cancer
Publicado: (2020)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Durvalumab for urothelial carcinoma, non-small cell lung cancer
Publicado: (2019)

Entrectinib for non-small cell lung cancer and solid tumours
Publicado: (2020)

B-Cell Acute Lymphoblastic Leukaemia of the Uterus
por: Vanheule, Eva, et al.
Publicado: (2020)

Case series of precursor B-cell lymphoblastic lymphoma
por: Kim, Jin Yong, et al.
Publicado: (2014)

Primary pleural precursor B-Cell lymphoblastic lymphoma
por: Williams, Mark S, et al.
Publicado: (2015)

Association of ARID5B Genetic Variants with Risk of Childhood B Cell Precursor Acute Lymphoblastic Leukaemia in Latvia
por: Kreile, Madara, et al.
Publicado: (2018)

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
por: Forero-Castro, Maribel, et al.
Publicado: (2017)

Elasomeran+davesomeran for prevention of COVID-19
Publicado: (2023)

Tozinameran+riltozinameran and tozinameran+famtozinameran for prevention of COVID-19
Publicado: (2023)

Finerenone for chronic kidney disease associated with type 2 diabetes with albuminuria
Publicado: (2023)

Opicapone for Parkinson’s disease
Publicado: (2023)

MYOCRISIN
Publicado: (1941)

Peramivir for influenza
Publicado: (2019)

Guselkumab for plaque psoriasis
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_il0njlo2ge0ee21ho6tcmdrh33